Mannheimia varigena is an occasional respiratory pathogen of cattle and pigs. We present the first four complete closed genome sequences of this species.
annheimia varigena is a Gram-negative rod bacterium that is infrequently associated with severe acute hemorrhagic fibrinonecrotic bronchopneumonia in feedlot cattle (1) . M. varigena is an opportunistic pathogen that can be found in the nasopharynxes of asymptomatic cattle and other ruminants (2, 3) . The bovine respiratory disease complex (BRDC) progression to bronchopneumonia results from host, pathogen, and environmental interactions that are not completely understood. Stress, viral infections, extreme weather changes, transportation, and other factors appear to predispose cattle to bronchopneumonia that is symptomatic of BRDC (4). Little is known of the genetic elements that may enhance or contribute to the virulence potential of M. varigena. Accordingly, we report here the first four complete closed genome sequences of M. varigena. All sequenced isolates were recovered from lung tissue samples at necropsy from animals with shipping fever.
Species identification of M. varigena isolates was verified on the OmniLog microbial identification system (Biolog, Hayward, CA). Genomic DNA of M. varigena isolates USDA-ARS-USMARC-1261, -1296, -1312, and -1388 was extracted using a blood and cell culture DNA kit (Qiagen, Valencia CA). Sequencing was performed on a Pacific Biosciences RSII instrument (Pacific Biosciences, Menlo Park, CA) using libraries prepared with the manufacturer's kits at a 15-kb insert size and with the P4/C2 version of chemistry. The read coverages for the four genomes varied from 11-to 25-fold after error correction with PBcR (5), while the minimum read length varied from 6 to 11 kb. Reads were assembled using Celera assembler version 7 (5), which produced a single large contig for each isolate that was then validated and improved using Quiver (6) . For all isolates, a self-self dot plot of the consensus sequences revealed at least a 1.5-kb overlap between the ends of the contig at Ͼ99% identity, consistent with a circular chromosome. Duplicated sequence was removed from the 3= end of each isolate to generate the proper circularized sequence. The origin of replication was approximated using GenSkew (http://genskew.csb .univie.ac.at), and a new linear model of the chromosome was generated using this origin position as base 1. The validity of the circularization was verified by mapping all the raw PacBio reads to this final model (including across the junction where circularization had been enforced) using Quiver, which also resolves remaining sequence errors to generate assemblies with Ͼ99.9% accuracy. A local instance of Do-It-Yourself Annotator (DIYA) (7) was used to annotate the circularized chromosome.
For M. varigena USDA-ARS-USMARC-1261, -1296, -1312, and -1388, the genome sizes were determined to be 2,393,449, 2,245,238, 2,131,927, and 2,228,291 bp, with gene counts of 2,622, 2,190, 2,062, and 2,176, coding sequence (CDS) counts of 2,381, 2,109, 1,982, and 2,096, and tRNA counts of 61, 61, 60, and 60, respectively, and rRNA counts of 20.
Nucleotide sequence accession numbers. The GenBank nucleotide sequence accession numbers for USDA-ARS-USMARC-1261, -1296, -1312, and -1388 are CP006942, CP006943, CP006944, and CP006953, respectively. The views and conclusions contained in this document are those of the authors and should not be interpreted as necessarily representing the official policies, either expressed or implied, of the U.S. Department of Homeland Security. In no event shall the DHS, NBACC, or Battelle National Biodefense Institute (BNBI) have any responsibility or liability for any use, misuse, inability to use, or reliance upon the information contained herein. The Department of Homeland Security does not endorse any products or commercial services mentioned in this publication.
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